Biochemical Engineering Special Interest Group
biological engineering professionals
30 January 2018

Evonetix raises $12.3m growth capital co-led from California

Evonetix, a Cambridge UK gene synthesis business, has completed a $12.3 million financing to advance the development of its technology, an innovative approach to enable scalable and high-fidelity gene synthesis. The financing was co-led by DCVC (Data Collective) of Palo Alto and European-based Draper Esprit, and included the Morningside group, alongside existing investors Providence Investment Company (Jersey), Cambridge Consultants, and San Francisco duo Rising Tide Fund and Civilization. Source: Business Weekly 30/1/2018

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).